Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings

Published:2017-03 Issue: Volume:56 Page:190-193
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Sotgiu Giovanni,Tiberi Simon,Centis Rosella,D’Ambrosio Lia,Fuentes Zhenia,Zumla Alimuddin,Migliori Giovanni Battista

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference31 articles.

1. Global tuberculosis report 2015. WHO/HTM/TB/2015.22;World Health Organization,2015

2. Multidrug-resistant tuberculosis around the world: what progress has been made?;Falzon;Eur Respir J,2015

3. Drug resistance beyond extensively drug resistant tuberculosis: individual patient data meta-analysis;Migliori;Eur Respir J,2013

4. Towards tuberculosis elimination: an action framework for low-incidence countries;Lönnroth;Eur Respir J,2015

5. European National Programme Representatives. Tuberculosis elimination: theory and practice in Europe;D’Ambrosio;Eur Respir J,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Faster, higher, stronger: the evolution of clinical perspectives on pan-TB;One Health & Implementation Research;2024-06-27

2. Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region;IJTLD OPEN;2024-03-01

3. Parameters of Complete Blood Count and Blood Chemistry during Treatment of Patients with MDR/XDR Pulmonary Tuberculosis with a Short-Course Regimen Containing Bedaquiline, Pretomanid, and Linezolid;Tuberculosis and Lung Diseases;2023-08-28

4. At Long Last: Short, All-Oral Regimens for Multidrug-Resistant Tuberculosis in the United States;Open Forum Infectious Diseases;2023-04-01

5. Efficacy of Replacing Linezolid with OTB-658 in Anti-Tuberculosis Regimens in Murine Models;Antimicrobial Agents and Chemotherapy;2023-02-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3